9 studies were found.

1.		Recruiting	Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma Condition: adult brain tumor
2.		Recruiting	Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction Conditions: adult non-Hodgkin's lymphoma; adult primary liver cancer; adult solid tumor
3.		Recruiting	Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia Conditions: stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
4.		Recruiting	Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
5.		Recruiting	Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer Condition: recurrent non-small cell lung cancer
6.		Recruiting	Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia Conditions: blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
7.		Recruiting	Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
8.		Recruiting	Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate Conditions: stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
9.		Recruiting	Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Lung Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer